《大行報告》友邦(01299.HK)投資評級及目標價(表)
多間券商(包括摩根士丹利、高盛及瑞銀等)發表報告均料友邦保險(01299.HK)將於下週五(29日)開市前公佈今年首季新業務摘要,受累於本港第五波疫情、東盟國家貨幣兌美元按年貶值等因素影響下,本網綜合9間券商預測,友邦2022年首季新業務價值介乎8.21億美元至9.38億美元,較2021年首季新業務價值10.52億美元計,按年下跌10.8%至22%;中位數爲8.39億美元,按年跌20%。
投資者將關注新冠疫情反覆對友邦短期業務的影響,包括內地及東南亞市場保險銷售活動會面臨壓力,聚焦管理層最新指引。
下表列出17間券商予其評級及目標價:
券商│投資評級│目標價(港元)
大和│買入│142元
星展│買入│127元
摩根士丹利│增持│124元
華泰證券│買入│120元
瑞銀│買入│110元
中金│跑贏行業│108元
大華繼顯│買入│105.3元
摩根大通│增持│102元
瑞信│跑贏大市│102元
高盛│買入(「確信買入」名單)│101元
裏昂│買入│100元
匯豐環球研究│買入│100元
美銀證券│買入│100元
富瑞│買入│100元
銀河-聯昌│收集│100元
中信證券│買入│94元
野村│買入│91.26元
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.